Range and determinants of white blood cell count in a large survey of Israelis without inflammation

Israel Medical Association Journal

Volumn 11, Issue 6, 2009, Pages 363-366

  Steinvil, Arie ^a   Berliner, Shlomo ^a   Herishanu, Yair ^a,b   Paran, Yael ^a   Justo, Dan ^a   Cohen, Michael ^a   Shapira, Itzhak ^a   Rogowski, Ori ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

C reactive protein; Reference values; White blood cell count

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; ISRAEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEUTROPHIL COUNT; PHYSICAL ACTIVITY; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DATA COLLECTION; DATABASES, FACTUAL; FEMALE; HUMANS; INFLAMMATION; ISRAEL; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; YOUNG ADULT;

EID: 69249138801     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
2. Gotsman I, Stabholz A, Planer D, et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease indicators of an active inflammatory burden? Isr Med Assoc J 2008; 10: 494-8.
3. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 2005; 25: 658-70.
4. Grau AJ, Boddy AW, Dukovic DA, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004; 35: 1147-52.
5. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004; 44: 1945-56.
6. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-44.
7. Blum A, Sheiman J, Hasin Y. Leukocytes and acute myocardial infarction. Isr Med Assoc J 2002; 4: 1060-5.
8. Sela S, Shurtz-Swirski R, Awad J, et al. The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. Isr Med Assoc J 2002; 4: 1015-19.
9. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43.
10. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997; 145: 416-21.
11. Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004; 25: 1287-92.
12. Schwartz J, Weiss ST. Host and environmental factors influencing the peripheral blood leukocyte count. Am J Epidemiol 1991; 134: 1402-9.
13. Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007; 146: 486-92.
14. Fisch IR, Freedman SH. Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA 1975; 234: 500-6.
15. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
16. Herishanu Y, Rogowski O, Polliack A, Marilus R. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006; 76: 516-20.
17. Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S. Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart (British Cardiac Society) 2007; 93: 940-4.
18. Berliner S, Shapira I, Toker S, Melamed S, Shirom A, Rogowski O. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol Dis 2005; 34: 135-40.
19. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-41.
20. NCEP/ATPIII. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
21. ICDC. MABAT Survey - The first Israeli health status and food survey - Part A. 1991-2001; Available from: http://www.health.gov.il/download/ pages/meyuhad.pdf.
22. Jotkowitz AB, Novack V, Rabinowitz G, Segal AR, Weitzman R, Porath A. A national study on lipid management. Eur J Intern Med 2008; 19: 356-61.
23. Kitai E, Vinker S, Halperin L, Meidan A, Grossman E. Pre-hypertension is a common phenomenon: national database study. Isr Med Assoc J 2007; 9: 8-11.
24. Tekes-Manova D, Israeli E, Shochat T, et al. The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years. Isr Med Assoc J 2006; 8: 527-31.
25. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002; 40: 1761-8.